Bringing Together Innovators, Leading Investors and Major Healthcare Corporations
The 27th MedTech Investing Europe Conference was held on 27 - 28 November 2018 at The Honourable Artillery Company (HAC) in London, United Kingdom. We welcomed over 100 attendees and showcased an unrivalled roster of venture-stage healthcare and life science companies.
Our programme included a mix of leading investors and healthcare industry specialists with a range of topical debates, from a look at how different investors are funding the next wave of healthcare companies to globalised healthcare and corss-border venture capital.
The next MTI event will be taking place 7-8 May 2019 in Lausanne, Switzerland once again bringing together venture-stage companies with our unrivalled investor community made up of some of the most pro-active VC and PE funds, the world's biggest healthcare corporations, single family offices and private multi-family offices worth at least €100 million as well as private investors, angels and many more. Financiers will be attending from 4 continents and represent some of the most active and innovative investors in the sector.
For more information about the May 2019 event please contact Peter Newton on firstname.lastname@example.org and check back to this website for updates, news and confirmed participants.
MTI speakers represent some of the most successful investors, entrepreneurs and life science specialists in the sector. Chosen for their knowledge, insight and first-hand experience they will give our audience the tools they need to develop winning investment strategies, successful commercialisation plans and accurately plan for the future.
To enquire about speaking opportunities at May 2019's Lausanne event, please contact Peter Newton, email@example.com or +44(0)203 763 2800.
Over the last 27 events we have showcased over 950 venture-stage healthcare and life science companies to our unrivalled audience of investors. Representing all areas of healthcare and life sciences our presenting companies originate from over 37 countries and are at a range of different stages from pre-clinical to commercialisation. Just some of the previous companies include:
For more information on how you can participate please email firstname.lastname@example.org.